Aurobindo Pharma Establishes New Wholly Owned Subsidiary for Manufacturing in Indonesia

<h1>Aurobindo Pharma Establishes New Wholly Owned Subsidiary for Manufacturing in Indonesia</h1>

Aurobindo Pharma Ltd has expanded its operational footprint by having a subsidiary incorporate a new wholly owned entity, PT Auro Pharm Indonesia, in Indonesia. This move is set up to handle manufacturing operations within the Southeast Asian market.

The new company operates as a wholly owned step down subsidiary of the Company and falls under the Pharmaceuticals industry. The incorporation aimed at establishing production capacity specifically within the Indonesian market.

Details regarding the newly incorporated entity and its initial capitalization are provided below:

<table>
<thead>
<tr>
<th>Detail</th>
<th>Information</th>
</tr>
</thead>
<tbody>
<tr>
<td>Entity Name</td>
<td>PT Auro Pharm Indonesia</td>
</tr>
<tr>
<td>Incorporation Date</td>
<td>July 1, 2026</td>
</tr>
<tr>
<td>Approval Date</td>
<td>July 9, 2026</td>
</tr>
<tr>
<td>Industry</td>
<td>Pharmaceuticals</td>
</tr>
</tbody>
</table>

The transaction involves the complete subscription of share capital in cash. The initial subscription to the share capital was set at IDR 20,000,000,000, which is divided into 2000 equity shares priced at IDR 10,000 each.

The transaction encompasses a 100% stake in the new entity. The Company confirmed that promoters and the promoter group hold no interest in this specific related party transaction.

AUROPHARMA Stock Price Movement​

Aurobindo Pharma shares slip as of 1:06 PM, shedding 1.35% in live trading to trade at ₹1565.9. The stock experienced significant movement today and remains near its day’s low of ₹1544.3, with over 769,732 shares exchanged so far.